TodayApril 15, 2022

Ovarian cancer kills half of the women diagnosed with the disease

The American Cancer Society estimates for ovarian cancer in the United States for 2021 are:
21,410 women will receive a new diagnosis of ovarian cancer.
13,770 women will die from ovarian cancer.

Moreover, 80% of ovarian cancer diagnoses occur only after the disease has progressed to a late stage.

Are all cancers treated equally?

For over 30 years, a PSA test has been the blood test given to men in prostate cancer screening. This simple blood test measures how much prostate-specific antigen is in his blood.

Breast cancer can be diagnosed in women through multiple tests, including a mammogram, ultrasound, MRI, and biopsy. A mammogram is done on women who have no family history of breast cancer.

Ovarian cancer is the fifth-leading cause of death from cancer in women. Doctors do not tell women about ovarian cancer and misdiagnose it many times as irritable bowel syndrome (IBS). Even in women with a family history of ovarian cancer, the CA-125 blood test is not required or given.

Just like a PSA test, a CA-125 test measures the amount of the protein (cancer antigen 125) in a woman’s blood for ovarian cancer, but because the test is not conclusive, doctors don’t give it to women until they are almost certain the woman has cancer. But what if they started giving the CA-125 when a female started puberty, and then every ten years after that?

Is there an early detection test for ovarian cancer? What if you found cancer early enough to make a difference?

By the time many women are diagnosed with ovarian cancer, they are stage 3 or stage 4, and the cure is chemotherapy and surgery to sterilize them. That’s right; their entire reproductive system is taken out of their body. They are then given more chemotherapy, and still, it is too late for half of them.

The Five-year survival rate for prostate cancer is 98%, Breast cancer survival rate is 90%, while ovarian cancer five-year survival rate is only 48%. That’s right; less than half of women with ovarian cancer will be alive in five years.

And yet, there is still not a test to detect ovarian cancer.

There are trials with blood tests being tested for early detection of cancer. A novel blood test by Michael V. Seiden accurately detected more than 50 types of cancer with a specificity of 99.3%.

For the 12 prespecified cancer types – anal, bladder, colorectal, esophageal, head, and neck, liver/bile duct, lung, ovarian, pancreatic, and stomach cancers, plus lymphoma and plasma cell neoplasm – researchers reported sensitivity rates up to 92% in stage IV. These twelve cancers account for approximately two-thirds of U.S. cancer deaths each year.

How can there be a trial that was done in 2020 that measured ovarian cancer with a higher percentage than a CA-125, and it is not being used? 

How can a company base its sole existence on early detection of cancer through blood testing, and there is still not a test? How has a man had a PSA test for thirty years, and you can women that don’t have cancer history in their family have a mammogram for breast cancer, but there is NOTHING for ovarian cancer?

Why do women have to resort to gofundme accounts or be sponsored by a drug company to get the drugs they need to live for five years? 

What are the symptoms of Ovarian Cancer?

One of the biggest complaints among women that have ovarian cancer is that they were not told that any of the symptoms below could be symptoms of ovarian cancer.

*Bloating/abdominal distension
*Abdominal or pelvic pain
*Feeling full quickly after eating small amounts of food
*Urgency to use the bathroom
*Change in bathroom habits
*loss of appetite
*upset stomach, like you have irritable bowel syndrome (IBS)

If these symptoms persist, see a gynecologist and ask for a CA-125 blood test and a pet scan.

Watch for more stories on women’s health on driving the nation.

Lou Ann Hammond

Lou Ann Hammond is the CEO of Carlist and Driving the Nation. She is the co-host of Real Wheels Washington Post carchat every Friday morning and is the Automotive, energy correspondent for The John Batchelor Show and a Contributor to Automotive Electronics magazine headquartered in Korea. Hammond is a founding member of the Women's World Car of the Year #WWCOTY, and board member of the Women in Automotive.

One Comment

  1. Mel Grell Reply

    Why do all these lists miss saying shortness of breath? It seems like a major clue. know it was what got me into the ER where I was diagnosed.

Leave a Reply

Your email address will not be published.